Jiuden Pharmaceutical: The net profit attributable to the parent in the first quarter was 56.7361 million yuan, a year-on-year decrease of 54.89%.

Jiudian Pharmaceutical announced on April 24 that its operating income in the first quarter of 2026 reached 595 million yuan, a year-on-year decrease of 14.48%; net profit attributable to shareholders of the listed company was 56.7361 million yuan, a year-on-year decrease of 54.89%; basic earnings per share were 0.11 yuan.